Enanta Pharmaceuticals
ENTA
#7731
Rank
C$0.59 B
Marketcap
C$20.62
Share price
3.64%
Change (1 day)
100.43%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.32 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-22.34%
2024 -C$0.14 Billion-23.87%
2023 -C$0.19 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.19 Billion91.12%
2020 -C$94.92 Million-407.13%
2019 C$30.9 M-78.63%
2018 C$0.14 B117.97%
2017 C$66.35 M-574.65%
2016 -C$13.99 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$25.11 Million-137.98%
2012 C$66.09 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.90 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.42 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$9.37 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.19 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.68 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.63 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA